Epion Therapeutics
Clinical trials sponsored by Epion Therapeutics, explained in plain language.
-
Promising new eye treatment could halt vision loss from keratoconus
Disease control CompletedThis phase 3 trial tested a new type of corneal cross-linking that does not require removing the surface layer of the eye. It involved 398 people aged 8 to 45 with keratoconus, a condition that thins and bulges the cornea. The treatment uses riboflavin eye drops and ultraviolet l…
Phase: PHASE3 • Sponsor: Epion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising new eye treatment could halt vision loss from keratoconus
Disease control CompletedThis phase 3 trial tested a new way to treat keratoconus, a condition where the cornea thins and bulges, causing blurry vision. The treatment uses special eye drops and ultraviolet light to strengthen the cornea without removing its outer layer. 396 people aged 8 to 45 took part …
Phase: PHASE3 • Sponsor: Epion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC